In this phase III clinical study regarding ischemic stroke recovery after BNG-1 add-on treatment, the primary objective is achieved by the result revealing that concomitant BNG-1 treatment with Aspirin and Aspirin alone treatments had favorable rates for 56.1% to 23.8% at week 12 after initiation of treatments, respectively, and the favorable rate was higher in the BNG-1 plus Aspirin group than that in the Aspirin group with a statistical significance (p<0.0001).
撥打電話